Review
Copyright ©The Author(s) 2017.
World J Cardiol. Jun 26, 2017; 9(6): 470-480
Published online Jun 26, 2017. doi: 10.4330/wjc.v9.i6.470
Table 1 Differences in between physiological and pathological hypertrophy
Physiological hypertrophyPathological hypertrophy
Angiogenesis, release of VEGFPerivascular fibrosis and inflammation
Activation of IGF-1 pathway (IGF-1- > PI3K- > Akt)Activation of Angiotensin II, Catecholamine and Endotelin-1
No fibrosisMAPK and Calcineurin pathway
Normal gene expressionFibrosis, myocyte necrosis and apoptosis
Proportional chamber enlargementCardiac dysfunction
Table 2 Pathological mechanisms of atrial fibrillation in long-term athletes
Pathological mechanism
Atrial ectopic beats
Vagal nervous system
Atrial fibrosis
Atrial dilatation
Myocardial injury
Inflammation
Redox imbalance
Table 3 Indicators of right ventricle pathology
Episodes of syncope
> 1000 ventricular extra-systoles (or > 500 non-RV outflow tract) per 24 h; ventricular tachyarrhythmias; Q waves in precordial leads; augmented QRS duration
≥ 3 abnormal signal averaged electrocardiography parameters
Delayed gadolinium enhancement; RV ejection fraction < 45%, or wall motion abnormalities at CMRI; impaired RV strain imaging
Attenuated blood pressure response during exercise
Dilatation of RV outflow tract
Table 4 Adverse effects of energy drinks
Adverse effect
Hypertension
Palpitations/arrhythmias (atrial fibrillation)
QTc prolongation
Myocardial ischemia
Ischemic stroke/Transient ischemic attack
Epileptic seizure
Anxiety, insomnia, irritability
Psychosis/Mania